Health care-focused Deerfield Management leads Baltimore biotech's $40M round

Johns Hopkins-born Dracen Pharmaceuticals Inc. is developing drug technology born out of Johns Hopkins University.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.